| PERIOD ENDING | 31-Aug-09 | 31-Aug-08 | 31-Aug-07 | | Total Revenue | 31,984 | 54,661 | 56,372 | | Cost of Revenue | 20,362 | 34,099 | 38,456 | | | Gross Profit | 11,622 | 20,562 | 17,916 | | | Operating Expenses | | Research Development | 3,961 | 7,101 | 8,521 | | Selling General and Administrative | 8,381 | 12,704 | 13,615 | | Non Recurring | 2,027 | 16,512 | 1,961 | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,747) | (15,755) | (6,181) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (22) | 139 | (32) | | Earnings Before Interest And Taxes | (2,769) | (15,616) | (6,213) | | Interest Expense | 625 | 707 | 814 | | Income Before Tax | (3,394) | (16,323) | (7,027) | | Income Tax Expense | (99) | (125) | (1) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,295) | (16,198) | (7,026) | | | Non-recurring Events | | Discontinued Operations | (157) |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (3,452) | (16,198) | (7,026) | | Preferred Stock And Other Adjustments |
-
| (4,691) |
-
| | | Net Income Applicable To Common Shares | ($3,452) | ($20,889) | ($7,026) |
|
1.52% Nasdaq 0.00%
Income Statement
